Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation

American Journal of Pathology

Volumn 171, Issue 2, 2007, Pages 589-598

  Herrero Herranz, Eva ^a   Pardo, Luis A ^a   Bunt, Gertrude ^a   Gold, Ralf ^b,c   Stühmer, Walter ^a   Linker, Ralf A ^b,c  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; GLYCOPROTEIN; MESSENGER RNA; POTASSIUM CHANNEL;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEMYELINATION; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; MULTIPLE SCLEROSIS; NERVE FIBER; NONHUMAN; OLIGODENDROGLIA; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD;

EID: 34548299553     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.061241     Document Type: Article

References (55)

1. Ludwin SK: The pathogenesis of multiple sclerosis: relating human pathology to experimental studies. J Neuropathol Exp Neurol 2006, 65:305-318
2. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H: Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129:3165-3172
3. Brück W, Kuhlmann T, Stadelmann C: Remyelination in multiple sclerosis. J Neurol Sci 2003, 206:181-185
4. Prineas JW, Connell F: Remyelination in multiple sclerosis. Ann Neurol 1979, 5:22-31
5. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES: Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993, 33:137-151
6. Raine CS: The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 1997, 77:135-152
7. Levine JM, Reynolds R, Fawcett JW: The oligodendrocyte precursor cell in health and disease. Trends Neurosci 2001, 24:39-47
8. Carroll WM, Jennings AR: Early recruitment of oligodendrocyte precursors in CNS demyelination. Brain 1994, 117:563-578
9. Gensert JM, Goldman JE: Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997, 19:197-203
10. Ludwin SK: An autoradiographic study of cellular proliferation in remyelination of the central nervous system. Am J Pathol 1979, 95:683-696
11. Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J: The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 2002, 31:523-536
12. Sim FJ, Zhao C, Pendens J, Franklin RJ: The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 2002, 22:2451-2459
13. Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD: NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 2000, 20:6404-6412
14. + glial cells: a novel glial cell population in the adult brain. J Neuropathol Exp Neurol 1999, 58:1113-1124
15. Wolswijk G: Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 1998, 18:601-609
16. Chang A, Tourtellotte WW, Rudick R, Trapp BD: Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 2002, 346:165-173
17. Coman I, Aigrot MS, Seilhean D, Reynolds R, Girault JA, Zalc B, Lubetzki C: Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain 2006, 129:3186-3195
18. Hinks GL, Franklin RJ: Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci 2000, 16:542-556
19. Murtie JC, Zhou YX, Le TQ, Vana AC, Armstrong RC: PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination. Neurobiol Dis 2005, 19:171-182
20. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF: Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002, 8:1115-1121
21. Jurynczyk M, Jurewicz A, Bielecki B, Raine CS, Selmaj K: Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J Neuroimmunol 2005, 170:3-10
22. Liu A, Stadelmann C, Moscarello M, Bruck W, Sobel A, Mastronardi FG, Casaccia-Bonnefil P: Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders. J Neurosci 2005, 25:737-747
23. Pardo LA: Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 2004, 19:285-292
24. Neusch C, Rozengurt N, Jacobs RE, Lester HA, Kofuji P: Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination, J Neurosci 2001, 21:5429-5438
25. + channels and membrane depolarization regulate accumulation of the cyclin-dependent kinase inhibitors p27(Kip1) and p21(CIP1) in glial progenitor cells. J Neurosci 1999, 19:5380-5392
26. 1/S phase progression of the cell cycle. Proc Natl Acad Sci USA 2002, 99:2350-2355
27. Edwards L, Nashmi R, Jones O, Backx P, Ackerley C, Becker L, Fehlings MG: Upregulation of Kv 1.4 protein and gene expression after chronic spinal cord injury. J Comp Neurol 2002, 443:154-167
28. Vautier F, Belachew S, Chittajallu R, Gallo V: Shaker-type potassium channel subunits differentially control oligodendrocyte progenitor proliferation. Glia 2004, 48:337-345
29. Mullen KM, Rozycka M, Rus H, Hu L, Cudrici C, Zafranskaia E, Pennington MW, Johns DC, Judge SI, Calabresi PA: Potassium channels Kv1.3 and Kv1.5 are expressed on blood-derived dendritic cells in the central nervous system. Ann Neurol 2006, 60:118-127
30. Rus H, Pardo CA, Hu L, Darrah E, Cudrici C, Niculescu T, Niculescu F, Mullen KM, Allie R, Guo L, Wulff H, Beeton C, Judge SI, Kerr DA, Knaus HG, Chandy KG, Calabresi PA: The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci USA 2005, 102:11094-11099
31. Gold R, Linington C, Lassmann H: Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971
32. Sontheimer H, Trotter J, Schachner M, Kettenmann H: Channel expression correlates with differentiation stage during the development of oligodendrocytes from their precursor cells in culture. Neuron 1989, 2:1135-1145
33. 4 surface antigen isolated by cell sorting are able to differentiate into astrocytes or oligodendrocytes. Brain Res Dev Brain Res 1989, 46:115-122
34. Jung M, Kramer E, Grzenkowski M, Tang K, Blakemore W, Aguzzi A, Khazaie K, Chlichlia K, von Blankenfeld G, Kettenmann H: Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci 1995, 7:1245-1265
35. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stuhmer W, Wang X: International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005, 57:473-508
36. Schmidt K, Eulitz D, Veh RW, Kettenmann H, Kirchhoff F: Heterogeneous expression of voltage-gated potassium channels of the shaker family (Kv1) in oligodendrocyte progenitors. Brain Res 1999, 843: 145-160
37. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H: Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993, 365:27-32
38. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R: CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 2002, 8:620-624
39. Black JA, Dib-Hajj S, Baker D, Newcombe J, Cuzner ML, Waxman SG: Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci USA 2000, 97:11598-11602
40. Weber C, Mello dQ, Downie BR, Suckow A, Stuhmer W, Pardo LA: Silencing the activity and proliferative properties of the human Eagl potassium channel by RNA interference. J Biol Chem 2006, 281:13030-13037
41. + channel block. J Neurosci 1996, 16:2659-2670
42. Attali B, Wang N, Kolot A, Sobko A, Cherepanov V, Soliven B: Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J Neurosci 1997, 17:8234-8245
43. Wu HY, Dawson MR, Reynolds R, Hardy RJ: Expression of QKI proteins and MAP1B identifies actively myelinating oligodendrocytes in adult rat brain. Mol Cell Neurosci 2001, 17:292-302
44. Polito A, Reynolds R: NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat 2005, 207:707-716
45. Wilson HC, Scolding NJ, Raine CS: Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 2006, 176:162-173
46. Solanky M, Maeda Y, Ming X, Husar W, Li W, Cook S, Dowling P: Proliferating oligodendrocytes are present in both active and chronic inactive multiple sclerosis plaques. J Neurosci Res 2001, 65:308-317
47. Craner MJ, Hains BC, Lo AC, Black JA, Waxman SG: Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 2004, 127:294-303
48. Barres BA, Burne JF, Holtmann B, Thoenen H, Sendtner M, Raff MC: Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol Cell Neurosci 1996, 8:146-156
49. Stidworthy MF, Genoud S, Li WW, Leone DP, Mantei N, Suter U, Franklin RJ: Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 2004, 127:1928-1941
50. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc Natl Acad Sci USA 2001, 98:13942-13947
51. + channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation. J Immunol 2001, 166:936-944
52. Prineas JW, Kwon EE, Goldenberg PZ, Ilyas AA, Quarles RH, Benjamins JA, Sprinkle TJ: Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions. Lab Invest 1989, 61:489-503
53. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C: Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 2002, 125:1972-1979
54. Franklin RJ: Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002, 3:705-714
55. Lubetzki C, Williams A, Stankoff B: Promoting repair in multiple sclerosis: problems and prospects. Curr Opin Neurol 2005, 18: 237-244